---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-335150"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2026-08-05T20:15:17+00:00"
generated_at: "2026-08-05T20:16:17.929319+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# RxSight Q2 revenue $33.7M, product sales down 19% YoY; withdraws 2026 guidance

## Summary
- Product sales $27.2M (-19% YoY); LAL units 24,917; LDD units 12.
- Net loss $(12.1)M ($(0.29)/share); adjusted net loss $(4.6)M ($(0.11)/share).
- New CEO Aziz Mottiwala appointed; Alcon collaboration with up to $200M in payments.
- Next-gen Light Adjustable Technology platform announced; 2026 guidance withdrawn.
- Cash and investments $208.8M as of June 30, 2026.

## SEC filing metadata
- accession: 0001193125-26-335150
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2026-08-05T20:15:17+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000119312526335150/0001193125-26-335150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000119312526335150/rxst-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-335150
- JSON: https://secwatch.observer/filing/0001193125-26-335150.json
- Plain text: https://secwatch.observer/filing/0001193125-26-335150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.